» Articles » PMID: 11877485

Functionally Distinct Subsets of CD1d-restricted Natural Killer T Cells Revealed by CD1d Tetramer Staining

Overview
Journal J Exp Med
Date 2002 Mar 6
PMID 11877485
Citations 313
Authors
Affiliations
Soon will be listed here.
Abstract

CD1d-restricted natural killer (NK)T cells are known to potently secrete T helper (Th)1 and Th2 cytokines and to mediate cytolysis, but it is unclear how these contrasting functional activities are regulated. Using lipid antigen-loaded CD1d tetramers, we have distinguished two subsets of CD1d-restricted T cells in fresh peripheral blood that differ in cytokine production and cytotoxic activation. One subset, which was CD4(-), selectively produced the Th1 cytokines interferon gamma and tumor necrosis factor alpha, and expressed NKG2d, a marker associated with cytolysis of microbially infected and neoplastic cells. This subset up-regulated perforin after exposure to interleukin (IL)-2 or IL-12. In contrast, CD4(+) CD1d-restricted NKT cells potently produced both Th1 and Th2 cytokines, up-regulated perforin in response to stimulation by phorbol myristate acetate and ionomycin but not IL-2 or IL-12, and could be induced to express CD95L. Further, for both CD1d-restricted NKT cell subsets, we found that antigenic stimulation induced cytokine production but not perforin expression, whereas exposure to inflammatory factors enhanced perforin expression but did not stimulate cytokine production. These results show that the various activities of CD1d-restricted T cells in tumor rejection, autoimmune disease, and microbial infections could result from activation of functionally distinct subsets, and that inflammatory and antigenic stimuli may influence different effector functions.

Citing Articles

Can invariant Natural Killer T cells drive B cell fate? a look at the humoral response.

Palacios P, Santibanez A, Aguirre-Munoz F, Gutierrez-Vera C, Nino de Zepeda-Carrizo V, Gongora-Pimentel M Front Immunol. 2025; 16:1505883.

PMID: 40040714 PMC: 11876049. DOI: 10.3389/fimmu.2025.1505883.


Diverse NKT cells regulate early inflammation and neurological outcomes after cardiac arrest and resuscitation.

Tamura T, Cheng C, Villasenor-Altamirano A, Yamada K, Ikeda K, Hayashida K Sci Transl Med. 2024; 16(776):eadq5796.

PMID: 39630883 PMC: 11792709. DOI: 10.1126/scitranslmed.adq5796.


The surveillance of viral infections by the unconventional Type I NKT cell.

Rajashekar V, Stern L, Almeida C, Slobedman B, Abendroth A Front Immunol. 2024; 15:1472854.

PMID: 39355244 PMC: 11442276. DOI: 10.3389/fimmu.2024.1472854.


Thymic development of human natural killer T cells: recent advances and implications for immunotherapy.

Pellicci D, Tavakolinia N, Perriman L, Berzins S, Menne C Front Immunol. 2024; 15:1441634.

PMID: 39267746 PMC: 11390520. DOI: 10.3389/fimmu.2024.1441634.


Traversing the bench to bedside journey for iNKT cell therapies.

ONeal J, Mavers M, Jayasinghe R, Dipersio J Front Immunol. 2024; 15:1436968.

PMID: 39170618 PMC: 11335525. DOI: 10.3389/fimmu.2024.1436968.


References
1.
Lanier L, Chang C, Phillips J . Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol. 1994; 153(6):2417-28. View

2.
Bauer S, Groh V, Wu J, Steinle A, Phillips J, Lanier L . Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999; 285(5428):727-9. DOI: 10.1126/science.285.5428.727. View

3.
Cardell S, Tangri S, Chan S, Kronenberg M, Benoist C, Mathis D . CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice. J Exp Med. 1995; 182(4):993-1004. PMC: 2192275. DOI: 10.1084/jem.182.4.993. View

4.
Sumida T, Sakamoto A, Murata H, Makino Y, Takahashi H, Yoshida S . Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. J Exp Med. 1995; 182(4):1163-8. PMC: 2192293. DOI: 10.1084/jem.182.4.1163. View

5.
Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S, Inoue S . Metalloproteinase-mediated release of human Fas ligand. J Exp Med. 1995; 182(6):1777-83. PMC: 2192231. DOI: 10.1084/jem.182.6.1777. View